Cargando…

Rheumatoid Arthritis-associated Interstitial Lung Disease in Greece: A Multicentre Epidemiological and Clinical Study

Interstitial Lung Disease (ILD) represents one of the most severe complications of Rheumatoid Arthritis (RA). Preliminary data from the RA Greek cohort show a prevalence of 5.3%. Due to scarcity of data, little is known regarding the epidemiological and clinical features of Greek patients with RA-IL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karageorgas, Theofanis, Sidiropoulos, Prodromos, Vassilopoulos, Dimitrios, Boumpas, Dimitrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Mediterranean Journal of Rheumatology (MJR) 2018
Materias:	Research Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045942/ https://www.ncbi.nlm.nih.gov/pubmed/32185335 http://dx.doi.org/10.31138/mjr.29.4.236

Ejemplares similares

Twenty Years of Targeted Treatment in Rheumatoid Arthritis in the Greek Databases: Achievements and Unmet Needs
por: Sidiropoulos, Prodromos, et al.
Publicado: (2019)

Updated Greek Rheumatology Society Guidelines for the Management of Rheumatoid Arthritis
por: Vassilopoulos, Dimitrios, et al.
Publicado: (2020)

Health outcomes and unmet needs in patients with long-standing rheumatoid arthritis attending tertiary care in Greece: a cohort study
por: Boumpas, Dimitrios T., et al.
Publicado: (2019)

Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications
por: Sidiropoulos, Prodromos I, et al.
Publicado: (2008)

Real-Life Outcome of Lupus Nephritis with Current Therapies: Study Protocol of a Multicentre Observational Study
por: Pappa, Maria, et al.
Publicado: (2022)

Development of an ANCA-Associated Vasculitides Patient Registry in Greece
por: Thomas, Konstantinos, et al.
Publicado: (2020)

Study of the natural course and specific immunity after herpes zoster in patients with rheumatoid arthritis receiving biologic DMARDs
por: Thomas, Konstantinos, et al.
Publicado: (2017)

Real world, big data cost of pharmaceutical treatment for rheumatoid arthritis in Greece
por: Souliotis, Kyriakos, et al.
Publicado: (2019)

Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis
por: Choulaki, Christianna, et al.
Publicado: (2015)

Five-year prospective multi-center cohort study of patients with giant cell arteritis in Greece
por: Tsalapaki, Christina, et al.
Publicado: (2018)

Interstitial Pneumonia with Autoimmune Features (IPAF): A Single-Centre, Prospective Study
por: Karampeli, Maria, et al.
Publicado: (2020)

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance
por: Stagakis, Ilias, et al.
Publicado: (2012)

Multicenter Cross-sectional Study of Patients with Rheumatoid Arthritis in Greece: Results from a cohort of 2.491 patients
por: Thomas, Konstantinos, et al.
Publicado: (2018)

Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response
por: Nakou, Magda, et al.
Publicado: (2009)

Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group
por: Genitsaridi, Irini, et al.
Publicado: (2020)

Clinical features and outcomes of patients with myositis associated-interstitial lung disease
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Lack of Association of Variants Previously Associated with Anti-TNF Medication Response in Rheumatoid Arthritis Patients: Results from a Homogeneous Greek Population
por: Zervou, Maria I., et al.
Publicado: (2013)

Treatment Satisfaction, Patient Preferences, and the Impact of Suboptimal Disease Control in Rheumatoid Arthritis Patients in Greece: Analysis of the Greek Cohort of SENSE study
por: Sidiropoulos, Prodromos, et al.
Publicado: (2022)

Development and Implementation of a Pilot Registry for Monitoring the Efficacy and Safety of Novel Therapies in Patients with Systemic Lupus Erythematosus
por: Adamichou, Christina, et al.
Publicado: (2020)

Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations
por: Vassilopoulos, Dimitrios, et al.
Publicado: (2008)

Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study
por: Sebastiani, Marco, et al.
Publicado: (2023)

Infections in Patients with Rheumatoid Arthritis in the Era of Targeted Synthetic Therapies
por: Thomas, Konstantinos, et al.
Publicado: (2020)

Deciphering the Molecular Mechanism of Flares in Patients with Systemic Lupus Erythematosus through Single-Cell Transcriptome Analysis of the Peripheral Blood
por: Papanikolaou, Sofia, et al.
Publicado: (2022)

The Role of Myositis-Specific and Myositis-Associated Autoantibodies and the Activation of Type I Interferon Pathway in the Generation of Clinical Phenotypes of Inflammatory Myopathies
por: Skarlis, Charalampos, et al.
Publicado: (2023)

Clinical features of rheumatoid arthritis-associated interstitial lung disease
por: Wang, Ting, et al.
Publicado: (2015)

Rheumatoid arthritis-associated interstitial lung disease
por: Solomon, Joshua J, et al.
Publicado: (2012)

Epidemiology and clinical characteristics of interstitial lung disease in patients with rheumatoid arthritis from the JointMan database
por: Zhuo, Joe, et al.
Publicado: (2023)

Adjustment in anti-TNF therapy after initial response: long-term follow-up in patients with rheumatoid arthritis
por: Sidiropoulos, P, et al.
Publicado: (2003)

Investigating the role of “Immature Myeloid Cells” as Drivers of Inflammation and Disease Persistence in Psoriatic Arthritis
por: Grivas, Alexandros, et al.
Publicado: (2023)

Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study
por: Panopoulos, Stylianos, et al.
Publicado: (2018)

Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study
por: Nikoloudaki, Myrto, et al.
Publicado: (2023)

Interstitial Lung Disease in Rheumatoid Arthritis in the Era of Biologics
por: Picchianti Diamanti, A., et al.
Publicado: (2011)

The Multifaceted Aspects of Interstitial Lung Disease in Rheumatoid Arthritis
por: Cavagna, Lorenzo, et al.
Publicado: (2013)

Management of the Rheumatoid Arthritis Patient with Interstitial Lung Disease
por: Jani, Meghna, et al.
Publicado: (2017)

Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease
por: Kim, Yerin, et al.
Publicado: (2023)

Scleroderma specific autoantibodies in rheumatoid arthritis and Sjögren's syndrome patients with interstitial lung disease: Prevalence and associations
por: Koulouri, Vasiliki, et al.
Publicado: (2022)

Mitophagy Balance in Various Cell Subsets in Patients with ANCA-Associated Vasculitis and Correlation with the Presence of Anti-Neutrophil Cytoplasmic Antibodies
por: Banos, Aggelos, et al.
Publicado: (2020)

Apremilast for biologic-naïve, peripheral psoriatic arthritis, including patients with early disease: results from the APROACH observational prospective study
por: Sfikakis, Petros P., et al.
Publicado: (2023)

Biomarkers for interstitial lung disease and acute-onset diffuse interstitial lung disease in rheumatoid arthritis
por: Furukawa, Hiroshi, et al.
Publicado: (2021)

Anxiety and depression severity in neuropsychiatric SLE are associated with perfusion and functional connectivity changes of the frontolimbic neural circuit: a resting-state f(unctional) MRI study
por: Antypa, Despina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7b0q9n3eoq3fskt2d0knacnan7